JOLENE GROTHE, APRN, CDE
Diabetes Educator Registered Nurse in WICHITA, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
JOLENE GROTHE, APRN, CDE reported a CMS MIPS final score of 78.939/100 — below the 83.1 national average — and filed 5,594 Medicare Part D claims in 2023.
- 78.939/100
- MIPS score · -4 vs avg
- 6K
- Part D claims, 2023
- 33%
- generic prescribing
- $2.7K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
JOLENE GROTHE, APRN, CDE's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
79 27th percentile higher than 27% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
What does the federal data show about JOLENE GROTHE, APRN, CDE?
Near national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Kansas
How Diabetes Educator Registered Nurse compares to other specialties among Kansas providers
Diabetes Educator Registered Nurse share within Kansas
Diabetes Educator Registered Nurse is one of the more visible NUCC categories in Kansas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
JOLENE GROTHE, APRN, CDE's 2023 MIPS final score plotted against the Diabetes Educator Registered Nurse national average
- MIPS Final Score
- 78.939/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Diabetes Educator Registered Nurse) — 78.939/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Diabetes Educator Registered Nurse US NPIs
78.939/100 MIPS final score — 4.2 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Diabetes Educator Registered Nurse. Quality dim: 89.4225. Cost dim: 41.2075.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
JOLENE GROTHE, APRN, CDE appears in the CMS NPPES registry as a Diabetes Educator Registered Nurse provider holding APRN, CDE credentials at 8110 E 32ND ST N STE 125, WICHITA, KS, 67226, with a listed phone of (316) 330-3636. NPI 1104025493 was issued on 07/16/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GROTHE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 5,594 prescription claims written by this provider, covering 494 Medicare beneficiaries and totaling roughly $3.3 million in drug spend, split 67% brand-name and 33% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 78.939/100 for the 2023 performance year (Quality 89.4225, Cost 41.2075), compared with the national average of 83.1.
Diabetes Educator Registered Nurse is a narrow specialty nationwide, with 2,273 enrolled providers across 55 states and an average of 1,296 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1104025493 |
|---|---|
| Specialty | Diabetes Educator Registered Nurse |
| Credentials | APRN, CDE |
| Gender | Female |
| NPI Issued | 07/16/2007 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm JOLENE GROTHE, APRN, CDE's current license status, disciplinary history, and board certifications with the Kansas Board of Healing Arts in Kansas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for JOLENE GROTHE, APRN, CDE. Source: openpaymentsdata.cms.gov.
Total received
$2.7K
Largest payer
Corcept Therapeutics
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
67% brand-name claims vs 33% generic, on 5,594 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 9,546
- Total Day Supply
- 279,537
- Brand vs Generic
- 67% brand / 33% generic
- Brand Drug Cost
- $3.2M
- Generic Drug Cost
- $31K
Patient Demographics
- Average Patient Age
- 67.9 years
- Avg HCC Risk Score
- 1.77
- Gender Split
- 57% female / 43% male
- Age Distribution
- <65: 122, 65-74: 242, 75-84: 114, 85+: 16
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What JOLENE GROTHE, APRN, CDE prescribes most
Top Medicare Part D drugs by claim count, 2023
- Ozempic
Ozempic
654 claims
- Metformin Hcl Er
Metformin Hcl Er
412 claims
- Novolog Flexpen
Novolog Flexpen
317 claims
- Tresiba Flextouch …
Tresiba Flextouch U-200
296 claims
- Tresiba Flextouch …
Tresiba Flextouch U-100
295 claims
- Jardiance 196
Jardiance
196 claims
- Levothyroxine Sodium 181
Levothyroxine Sodium
181 claims
- Atorvastatin Calcium 158
Atorvastatin Calcium
158 claims
| Drug | Claims |
|---|---|
| Ozempic Semaglutide | 654 |
| Metformin Hcl Er Metformin Hcl | 412 |
| Novolog Flexpen Insulin Aspart | 317 |
| Tresiba Flextouch U-200 Insulin Degludec | 296 |
| Tresiba Flextouch U-100 Insulin Degludec | 295 |
| Jardiance Empagliflozin | 196 |
| Levothyroxine Sodium | 181 |
| Atorvastatin Calcium | 158 |
| Mounjaro Tirzepatide | 156 |
| Rosuvastatin Calcium | 154 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Diabetes Educator Registered Nurse Overview
How JOLENE GROTHE, APRN, CDE fits within the Diabetes Educator Registered Nurse landscape nationally.
JOLENE GROTHE, APRN, CDE's 5,594 claims are above the specialty average of 1,296.
Nearby Diabetes Educator Registered Nurse Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as GROTHE.
Compare Diabetes Educator Registered Nurse nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Kansas
Frequently Asked Questions
What is JOLENE GROTHE, APRN, CDE's specialty? ▼
How much does JOLENE GROTHE, APRN, CDE prescribe under Medicare Part D? ▼
What is JOLENE GROTHE, APRN, CDE's Medicare quality score? ▼
Where is JOLENE GROTHE, APRN, CDE located? ▼
What is JOLENE GROTHE, APRN, CDE's NPI number? ▼
Does JOLENE GROTHE, APRN, CDE prescribe more brand-name or generic drugs? ▼
How many Diabetes Educator Registered Nurse providers are there in the US? ▼
What drugs does JOLENE GROTHE, APRN, CDE prescribe most often? ▼
Does JOLENE GROTHE, APRN, CDE accept Medicare? ▼
How can I verify JOLENE GROTHE, APRN, CDE's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology